pe
pep-04817 v1 CC-BY-SA-4.0

Blood-pressure-lowering peptide (FQKVVAG)

A small peptide that blocks ACE, the enzyme that raises blood pressure, potentially helping to lower it; experimental, not yet an approved drug.

statusbioassayed targetACE length7 aa refs2
angiotensin-converting-enzyme-ace-inhibitorsanti-hypertensive
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 1.0
ipTM0.719
pTM0.682
avg pLDDT80.6
ranking score0.789
STRUCTURE · PEP-04817 × ACE
ranking0.789
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
boltz-2 1.0 · mmCIF ↓ download
sequence7 aa
157
FQKVVAG
details expand to inspect
full evidence table2 metrics
metricvaluetool
ipTM 0.7190289497375488 boltz-2
ranking score 0.7887774109840393 boltz-2
3-letter notation
Phe-Gln-Lys-Val-Val-Ala-Gly
recipeboltz-2 1.0
parametervalue
modelboltz-2 1.0
weights
hardwarenvidia_nim_api
mlx version
python
random seed
msa strategycolabfold_nvidia
diffusion samples1
runtime
predicted bymlx@peptide
predicted at2026-04-25
citationbibtex
peptidemodel (2026). Blood-pressure-lowering peptide (FQKVVAG) (pep-04817, v1). PeptideModel. https://peptidemodel.com/card/pep-04817
@peptide{pep04817,
  sequence = {FQKVVAG},
  target   = {ace},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 2 by signal overlap
references 2 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use